|
CA2289314A1
|
|
Chemotactic peptide antagonists for imaging sites of inflammation
|
|
AU5142899A
|
|
Immobilized labeling compounds and methods
|
|
CA2273609A1
|
|
Radiopharmaceuticals and methods for imaging
|
|
CA2266233A1
|
|
A novel n-formylpeptide analogue: a potential inflammation and infection imaging agent
|
|
CA2266298A1
|
|
Synthesis and evaluation of two technetium-99m-labeled peptidic 2-nitroimidazoles for imaging hypoxia
|
|
EP1056773A2
|
|
Angiogenesis targeting molecules
|
|
CA2260173A1
|
|
A method of treating tumours expressing low levels of neutral endopeptidase
|
|
CA2316392A1
|
|
Peptide chelators that predominately form a single stereoisomeric species upon coordination to a metal center
|
|
WO9910016A1
|
|
Combinatorial library
|
|
WO9900386A1
|
|
Dopamine d4 receptor ligands
|
|
US6334996B1
|
|
Chelators that predominantely form a single stereoisomeric species upon coordination to a metal center
|
|
US5976497A
|
|
Dopamine D4 receptor ligands
|
|
WO9801164A1
|
|
Tricyclic radiolabeled d4 receptor ligands
|
|
US6017511A
|
|
Glycopeptide-chelator conjugates
|
|
US5725838A
|
|
Radiolabeled D4 receptor ligands
|
|
US5688489A
|
|
Non-receptor mediated imaging agents
|
|
US5804158A
|
|
Sequestered imaging agents
|
|
AU1378395A
|
|
Metal chelators
|
|
AU8137694A
|
|
Immobilized labelling method
|
|
US5662885A
|
|
Peptide derived radionuclide chelators
|
